Atlas Trials

Evaluation of MDMA on Startle Response

Clinical trial NCT03181763 · COMPLETED

Trial details

NCT number
NCT03181763
Sponsor
Resilient Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Startle Response
Start date
2017-03-14
Primary completion
2020-08-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.